2018 USPSTF建议声明:前列腺癌筛查

2018-05-08 美国预防医学工作组 JAMA. 2018 May 8;319(18):1901-1913.

2018年5月,美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明,本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新,USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据,针对前列腺癌的筛查提出指导建议。

中文标题:

2018 USPSTF建议声明:前列腺癌筛查

英文标题:

Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.

发布机构:

美国预防医学工作组

发布日期:

2018-05-08

简要介绍:

2018年5月,美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明,本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新,USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据,针对前列腺癌的筛查提出指导建议。 

拓展指南:前列腺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 USPSTF建议声明:前列腺癌筛查)] GetToolGuiderByIdResponse(projectId=1, id=92c931c001598372, title=2018 USPSTF建议声明:前列腺癌筛查, enTitle=Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement., guiderFrom=JAMA. 2018 May 8;319(18):1901-1913., authorId=null, author=, summary=2018年5月,美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明,本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新,USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据,针对前列腺癌的筛查提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=121, associationName=美国预防医学工作组, associationIntro=由预防和循证医学的非联邦专家和初级保健提供者(如内科,儿科医生,家庭医生,妇科/产科医生,护士和健康行为专家)组成的非联邦小组。为初级保健医生和卫生系统提供指导意见和科学证据。, copyright=0, guiderPublishedTime=Tue May 08 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年5月,美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明,本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新,USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据,针对前列腺癌的筛查提出指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>前列腺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=4c8ca1c00159293c" title="前列腺癌经典内分泌治疗安全共识" target=_blank>前列腺癌经典内分泌治疗安全共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=324591c0015e95cc" title="2018 GETUG建议:中度前列腺癌大分割放疗的剂量限制" target=_blank>2018 GETUG建议:中度前列腺癌大分割放疗的剂量限制</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9fb421c0015e764f" title="NCCN临床实践指南:前列腺癌早期检测(2018.V2)" target=_blank>NCCN临床实践指南:前列腺癌早期检测(2018.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0fa341c0015e557a" title="前列腺癌化疗安全共识" target=_blank>前列腺癌化疗安全共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9a1df1c00156801b" title="NCCN临床实践指南:前列腺癌早期检测(2018.V1)" target=_blank>NCCN临床实践指南:前列腺癌早期检测(2018.V1)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" target=_blank>有关前列腺癌更多指南</a></ul>, tagList=[TagDto(tagId=3988, tagName=前列腺癌筛查)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4763, appHits=194, showAppHits=0, pcHits=3514, showPcHits=1506, likes=129, shares=7, comments=4, approvalStatus=1, publishedTime=Thu May 31 22:52:08 CST 2018, publishedTimeString=2018-05-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu May 31 22:52:08 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 05:55:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 USPSTF建议声明:前列腺癌筛查)])
2018 USPSTF建议声明:前列腺癌筛查
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=326499, encodeId=2190326499d0, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Sun Jun 24 02:08:57 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320392, encodeId=5256320392c1, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 01 00:24:34 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320382, encodeId=c3cf3203825b, content=不错的文章值得推荐一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 31 23:42:36 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320365, encodeId=b4e732036575, content=2018年5月.美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明.本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新.USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据.针对前列腺癌的筛查提出指导建议.?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu May 31 23:09:37 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-06-24 phoebeyan520

    学习了.谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=326499, encodeId=2190326499d0, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Sun Jun 24 02:08:57 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320392, encodeId=5256320392c1, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 01 00:24:34 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320382, encodeId=c3cf3203825b, content=不错的文章值得推荐一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 31 23:42:36 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320365, encodeId=b4e732036575, content=2018年5月.美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明.本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新.USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据.针对前列腺癌的筛查提出指导建议.?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu May 31 23:09:37 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-06-01 sunfeifeiyang

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=326499, encodeId=2190326499d0, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Sun Jun 24 02:08:57 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320392, encodeId=5256320392c1, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 01 00:24:34 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320382, encodeId=c3cf3203825b, content=不错的文章值得推荐一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 31 23:42:36 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320365, encodeId=b4e732036575, content=2018年5月.美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明.本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新.USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据.针对前列腺癌的筛查提出指导建议.?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu May 31 23:09:37 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 131****2916

    不错的文章值得推荐一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=326499, encodeId=2190326499d0, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Sun Jun 24 02:08:57 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320392, encodeId=5256320392c1, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 01 00:24:34 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320382, encodeId=c3cf3203825b, content=不错的文章值得推荐一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Thu May 31 23:42:36 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320365, encodeId=b4e732036575, content=2018年5月.美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明.本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新.USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据.针对前列腺癌的筛查提出指导建议.?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Thu May 31 23:09:37 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 有备才能无患

    2018年5月.美国预防医学工作组(USPSTF)更新发布了前列腺癌筛查的建议声明.本文是对2012年USPSTF基于前列腺特异性抗原(PSA)筛查前列腺癌建议的更新.USPSTF专家小组回顾了PSA筛查前列腺癌的获益和危害以及筛查前列腺癌之后的治疗的相关证据.针对前列腺癌的筛查提出指导建议.?

    0